AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
(From Chemical Business NewsBase - Australasian Biotechnology)
Agenix Ltd announced at the 51st Annual Society of Nuclear Medicine in Philadelphia, PA, its blood-clot imaging technology, Thromboview, showed promising safety and dosimetry results in a study. The study, which was conducted on 32 ...